[Clinical adverse effects and biochemical changes due to ovulation inhibitors].
D000293:Adolescent; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D002570:Ceruloplasmin / Q000032:analysis; D002764:Cholecystitis / Q000139:chemically induced; D002769:Cholelithiasis / Q000139:chemically induced; D004796:Clinical Enzyme Tests; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004361:Drug Tolerance; D004967:Estrogens / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007565:Jaundice / Q000139:chemically induced; D008099:Liver / Q000201:enzymology; D008111:Liver Function Tests; D008875:Middle Aged; D011372:Progestins / Q000009:adverse effects*
D003276:Contraceptives, Oral; D004967:Estrogens; D011372:Progestins; D002570:Ceruloplasmin; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase
Klinische Nebenwirkungen und biochemische Veränderungen unter Ovulationshemmern.